FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283397805> ?p ?o ?g. }

• W4283397805 endingPage "949.e2" @default.
• W4283397805 startingPage "937" @default.
• W4283397805 abstract "Proactive therapeutic drug monitoring (TDM) has been proposed to improve outcomes in patients with inflammatory bowel disease (IBD) treated with tumor necrosis factor (TNF)α antagonists. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing proactive TDM with conventional management in patients with IBD.We identified RCTs in patients with IBD treated with TNFα antagonists comparing proactive TDM (routine assessments of trough concentration with dose adjustments to maintain predetermined trough concentration, regardless of disease activity) with conventional management (clinically driven dose adjustments). The primary outcome was failure to maintain clinical remission. Certainty of evidence was appraised using Grading of Recommendations, Assessment, Development and Evaluations.On meta-analysis of 9 RCTs (8 RCTs in adults, and focusing on maintenance phase), there was no significant difference in the risk of failing to maintain clinical remission in patients who underwent proactive TDM (267/709; 38%) vs conventional management (292/696; 42%) (relative risk [RR], 0.96; 95% confidence interval [CI], 0.81-1.13) with moderate heterogeneity (inconsistency index = 36%) (Grading of Recommendations, Assessment, Development and Evaluations; low certainty evidence), with no differences in patients with Crohn's disease (RR, 0.87 ; 95% CI, 0.66-1.15) and ulcerative colitis (RR, 0.88; 95% CI, 0.72-1.07). Disease duration, concomitant immunomodulators, disease activity at baseline, and optimization of therapy before randomization did not modify this association. No differences were observed in risk of developing antidrug antibodies or serious adverse events. Patients in the proactive TDM arm were more likely to undergo dose escalation (RR, 1.56; 95% CI, 1.25-1.94).Routine proactive TDM to target biologic concentration to specific thresholds, regardless of disease activity, did not offer clinical benefit in patients with IBD treated with TNFα antagonists in RCTs conducted to date. We cannot exclude the possibility of benefit in disease subtypes and phases of therapy (induction) not represented in these RCT populations." @default.
• W4283397805 created "2022-06-25" @default.
• W4283397805 creator A5011957275 @default.
• W4283397805 creator A5021543041 @default.
• W4283397805 creator A5025438429 @default.
• W4283397805 creator A5032927378 @default.
• W4283397805 creator A5034135548 @default.
• W4283397805 creator A5035847062 @default.
• W4283397805 creator A5036883744 @default.
• W4283397805 creator A5045216057 @default.
• W4283397805 creator A5048193912 @default.
• W4283397805 creator A5090247807 @default.
• W4283397805 date "2022-10-01" @default.
• W4283397805 modified "2023-10-14" @default.
• W4283397805 title "Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis" @default.
• W4283397805 cites W2003835888 @default.
• W4283397805 cites W2022077807 @default.
• W4283397805 cites W2077421021 @default.
• W4283397805 cites W2107328434 @default.
• W4283397805 cites W2125435699 @default.
• W4283397805 cites W2135400982 @default.
• W4283397805 cites W2165010366 @default.
• W4283397805 cites W2320652365 @default.
• W4283397805 cites W2321351874 @default.
• W4283397805 cites W2725046187 @default.
• W4283397805 cites W2741466972 @default.
• W4283397805 cites W2744879509 @default.
• W4283397805 cites W2758846981 @default.
• W4283397805 cites W2769684727 @default.
• W4283397805 cites W2771096098 @default.
• W4283397805 cites W2781482422 @default.
• W4283397805 cites W2914225473 @default.
• W4283397805 cites W2919081348 @default.
• W4283397805 cites W2944945942 @default.
• W4283397805 cites W2949255324 @default.
• W4283397805 cites W2970684805 @default.
• W4283397805 cites W2978824500 @default.
• W4283397805 cites W3093762650 @default.
• W4283397805 cites W3111210633 @default.
• W4283397805 cites W3118615836 @default.
• W4283397805 cites W3157525851 @default.
• W4283397805 cites W3186840737 @default.
• W4283397805 cites W3190445083 @default.
• W4283397805 cites W4200136929 @default.
• W4283397805 cites W4206056576 @default.
• W4283397805 cites W4210258765 @default.
• W4283397805 cites W4210447725 @default.
• W4283397805 cites W4211117698 @default.
• W4283397805 doi "https://doi.org/10.1053/j.gastro.2022.06.052" @default.
• W4283397805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35753383" @default.
• W4283397805 hasPublicationYear "2022" @default.
• W4283397805 type Work @default.
• W4283397805 citedByCount "15" @default.
• W4283397805 countsByYear W42833978052022 @default.
• W4283397805 countsByYear W42833978052023 @default.
• W4283397805 crossrefType "journal-article" @default.
• W4283397805 hasAuthorship W4283397805A5011957275 @default.
• W4283397805 hasAuthorship W4283397805A5021543041 @default.
• W4283397805 hasAuthorship W4283397805A5025438429 @default.
• W4283397805 hasAuthorship W4283397805A5032927378 @default.
• W4283397805 hasAuthorship W4283397805A5034135548 @default.
• W4283397805 hasAuthorship W4283397805A5035847062 @default.
• W4283397805 hasAuthorship W4283397805A5036883744 @default.
• W4283397805 hasAuthorship W4283397805A5045216057 @default.
• W4283397805 hasAuthorship W4283397805A5048193912 @default.
• W4283397805 hasAuthorship W4283397805A5090247807 @default.
• W4283397805 hasBestOaLocation W42833978051 @default.
• W4283397805 hasConcept C112705442 @default.
• W4283397805 hasConcept C126322002 @default.
• W4283397805 hasConcept C168563851 @default.
• W4283397805 hasConcept C177713679 @default.
• W4283397805 hasConcept C197934379 @default.
• W4283397805 hasConcept C204243189 @default.
• W4283397805 hasConcept C2776207728 @default.
• W4283397805 hasConcept C2778260677 @default.
• W4283397805 hasConcept C2779134260 @default.
• W4283397805 hasConcept C2779384505 @default.
• W4283397805 hasConcept C2780272996 @default.
• W4283397805 hasConcept C2780479503 @default.
• W4283397805 hasConcept C44249647 @default.
• W4283397805 hasConcept C71924100 @default.
• W4283397805 hasConcept C82789193 @default.
• W4283397805 hasConcept C95190672 @default.
• W4283397805 hasConceptScore W4283397805C112705442 @default.
• W4283397805 hasConceptScore W4283397805C126322002 @default.
• W4283397805 hasConceptScore W4283397805C168563851 @default.
• W4283397805 hasConceptScore W4283397805C177713679 @default.
• W4283397805 hasConceptScore W4283397805C197934379 @default.
• W4283397805 hasConceptScore W4283397805C204243189 @default.
• W4283397805 hasConceptScore W4283397805C2776207728 @default.
• W4283397805 hasConceptScore W4283397805C2778260677 @default.
• W4283397805 hasConceptScore W4283397805C2779134260 @default.
• W4283397805 hasConceptScore W4283397805C2779384505 @default.
• W4283397805 hasConceptScore W4283397805C2780272996 @default.
• W4283397805 hasConceptScore W4283397805C2780479503 @default.
• W4283397805 hasConceptScore W4283397805C44249647 @default.
• W4283397805 hasConceptScore W4283397805C71924100 @default.
• W4283397805 hasConceptScore W4283397805C82789193 @default.

• next